TIDMHIK

RNS Number : 3526O

Hikma Pharmaceuticals Plc

02 October 2023

Hikma Pharmaceuticals PLC

Block Listing Six Monthly Return

Date: 2 October 2023

 
 Name of applicant:                  Hikma Pharmaceuticals PLC 
 Name of scheme:                     Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("2018 MIP") and Hikma 
                                     Pharmaceuticals 
                                     PLC 2014 Executive Incentive Plan ("EIP") (together "the Plans") 
                                    ---------------------------------------------------------------------------------- 
 Period of return                    From: 1 April 2023                  To:        30 September 2023 
                                    ----------------------------------  ---------  ----------------------------------- 
 Balance of unallotted securities    The Plans: 1,497,913 Ordinary Shares of 10 pence 
 under scheme(s) from previous 
 return: 
                                    ---------------------------------------------------------------------------------- 
 Plus: The amount by which the       The Plans: 0 Ordinary Shares of 10 pence 
 block scheme(s) has been 
 increased since the date of the 
 last 
 return (if any increase has been 
 applied for): 
                                    ---------------------------------------------------------------------------------- 
 Less: Number of securities          2018 MIP: 438 Ordinary Shares of 10 pence 
 issued/allotted under scheme(s)      EIP: 378,765 Ordinary Shares of 10 pence 
 during period (see LR3.5.7G): 
                                    ---------------------------------------------------------------------------------- 
 Equals: Balance under scheme(s)     The Plans: 1,118,710 Ordinary Shares of 10 pence 
 not yet issued/allotted at end of 
 period: 
                                    ---------------------------------------------------------------------------------- 
 
 
 Name of contact:                Hussein Arkhagha 
 Telephone number of contact:    +44(0)20 7399 2760 
                                -------------------

LEI: 549300BNS685UXH4JI75

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRUPGPGUUPWUBP

(END) Dow Jones Newswires

October 02, 2023 05:13 ET (09:13 GMT)

Hikma Pharmaceuticals (LSE:HIK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Hikma Pharmaceuticals.
Hikma Pharmaceuticals (LSE:HIK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Hikma Pharmaceuticals.